293 related articles for article (PubMed ID: 28776441)
1. Economic evaluation of outpatient parenteral antimicrobial therapy: a systematic review.
Psaltikidis EM; Silva END; Bustorff-Silva JM; Moretti ML; Resende MR
Expert Rev Pharmacoecon Outcomes Res; 2017 Aug; 17(4):355-375. PubMed ID: 28776441
[TBL] [Abstract][Full Text] [Related]
2. Cost-utility analysis of outpatient parenteral antimicrobial therapy (OPAT) in the Brazilian national health system.
Psaltikidis EM; Silva END; Moretti ML; Trabasso P; Stucchi RSB; Aoki FH; Cardoso LGO; Höfling CC; Bachur LF; Ponchet DDF; Colombrini MRC; Tozzi CS; Ramos RF; Costa SMQ; Resende MR
Expert Rev Pharmacoecon Outcomes Res; 2019 Jun; 19(3):341-352. PubMed ID: 30362845
[TBL] [Abstract][Full Text] [Related]
3. Mandatory infectious diseases approval of outpatient parenteral antimicrobial therapy (OPAT): clinical and economic outcomes of averted cases.
Conant MM; Erdman SM; Osterholzer D
J Antimicrob Chemother; 2014 Jun; 69(6):1695-700. PubMed ID: 24532684
[TBL] [Abstract][Full Text] [Related]
4. Outpatient parenteral antimicrobial therapy for infective endocarditis: a cost-effective strategy.
Lacroix A; Revest M; Patrat-Delon S; Lemaître F; Donal E; Lorléac'h A; Arvieux C; Michelet C; Tattevin P
Med Mal Infect; 2014 Jul; 44(7):327-30. PubMed ID: 25022891
[TBL] [Abstract][Full Text] [Related]
5. Costs of outpatient parenteral antimicrobial therapy (OPAT) administered by Hospital at Home units in Spain.
González-Ramallo VJ; Mirón-Rubio M; Mujal A; Estrada O; Forné C; Aragón B; Rivera AJ
Int J Antimicrob Agents; 2017 Jul; 50(1):114-118. PubMed ID: 28499957
[TBL] [Abstract][Full Text] [Related]
6. Outcomes and cost minimisation associated with outpatient parenteral antimicrobial therapy (OPAT) for foot infections in people with diabetes.
Malone M; West D; Xuan W; Lau NS; Maley M; Dickson HG
Diabetes Metab Res Rev; 2015 Sep; 31(6):638-45. PubMed ID: 25850572
[TBL] [Abstract][Full Text] [Related]
7. Outpatient parenteral antimicrobial therapy (OPAT) versus inpatient care in the UK: a health economic assessment for six key diagnoses.
Dimitrova M; Gilchrist M; Seaton RA
BMJ Open; 2021 Sep; 11(9):e049733. PubMed ID: 34588251
[TBL] [Abstract][Full Text] [Related]
8. Selecting antibacterials for outpatient parenteral antimicrobial therapy : pharmacokinetic-pharmacodynamic considerations.
Slavik RS; Jewesson PJ
Clin Pharmacokinet; 2003; 42(9):793-817. PubMed ID: 12882587
[TBL] [Abstract][Full Text] [Related]
9. Impact of a multidisciplinary team review of potential outpatient parenteral antimicrobial therapy prior to discharge from an academic medical center.
Heintz BH; Halilovic J; Christensen CL
Ann Pharmacother; 2011 Nov; 45(11):1329-37. PubMed ID: 21990938
[TBL] [Abstract][Full Text] [Related]
10. Delivery, setting and outcomes of paediatric Outpatient Parenteral Antimicrobial Therapy (OPAT): a scoping review.
Carter B; Carrol ED; Porter D; Peak M; Taylor-Robinson D; Fisher-Smith D; Blake L
BMJ Open; 2018 Nov; 8(11):e021603. PubMed ID: 30446572
[TBL] [Abstract][Full Text] [Related]
11. Clinical efficacy, cost analysis and patient acceptability of outpatient parenteral antibiotic therapy (OPAT): a decade of Sheffield (UK) OPAT service.
Durojaiye OC; Bell H; Andrews D; Ntziora F; Cartwright K
Int J Antimicrob Agents; 2018 Jan; 51(1):26-32. PubMed ID: 28673610
[TBL] [Abstract][Full Text] [Related]
12. Outpatient parenteral antimicrobial therapy (OPAT) in the UK: a cross-sectional survey of acute hospital trusts and health boards.
Durojaiye OC; Cartwright K; Ntziora F
Diagn Microbiol Infect Dis; 2019 Jan; 93(1):58-62. PubMed ID: 30098851
[TBL] [Abstract][Full Text] [Related]
13. Outpatient parenteral antimicrobial therapy (OPAT): is it safe for selected patients to self-administer at home? A retrospective analysis of a large cohort over 13 years.
Matthews PC; Conlon CP; Berendt AR; Kayley J; Jefferies L; Atkins BL; Byren I
J Antimicrob Chemother; 2007 Aug; 60(2):356-62. PubMed ID: 17566002
[TBL] [Abstract][Full Text] [Related]
14. Cost analysis of an adult outpatient parenteral antibiotic therapy (OPAT) programme. A Canadian teaching hospital and Ministry of Health perspective.
Wai AO; Frighetto L; Marra CA; Chan E; Jewesson PJ
Pharmacoeconomics; 2000 Nov; 18(5):451-7. PubMed ID: 11151398
[TBL] [Abstract][Full Text] [Related]
15. An Assessment of an Outpatient Antimicrobial Therapy Program in a Rural Medical Center : A Retrospective Chart Review.
Burkett MS; Macci Bires A; Cline TW; Knight A
Crit Care Nurs Q; 2018; 41(2):109-120. PubMed ID: 29494367
[TBL] [Abstract][Full Text] [Related]
16. Cost-analysis of inpatient and outpatient parenteral antimicrobial therapy in orthopaedics: A systematic literature review.
Boese CK; Lechler P; Frink M; Hackl M; Eysel P; Ries C
World J Clin Cases; 2019 Jul; 7(14):1825-1836. PubMed ID: 31417928
[TBL] [Abstract][Full Text] [Related]
17. Current status in outpatient parenteral antimicrobial therapy: a practical view.
Candel FJ; Julián-Jiménez A; González-Del Castillo J
Rev Esp Quimioter; 2016 Apr; 29(2):55-68. PubMed ID: 27014770
[TBL] [Abstract][Full Text] [Related]
18. Ambulatory use of parenteral antibacterials: contemporary perspectives.
Leggett JE
Drugs; 2000; 59 Suppl 3():1-8; discussion 47-9. PubMed ID: 10845408
[TBL] [Abstract][Full Text] [Related]
19. Outcomes from global adult outpatient parenteral antimicrobial therapy programmes: a review of the last decade.
MacKenzie M; Rae N; Nathwani D
Int J Antimicrob Agents; 2014 Jan; 43(1):7-16. PubMed ID: 24200469
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and cost-effectivity analysis of outpatient parenteral antimicrobial therapy unit in infectious disease clinical practices: Turkey perspective.
Bastug A; Oksuz E; Kazancioglu S; Malhan S; Ozbay BO; Bodur H
Int J Clin Pract; 2021 Jun; 75(6):e14147. PubMed ID: 33709495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
